Labcorp Holdings Inc.
General ticker "LH" information:
- Sector: Health Care
- Industry: Medical - Equipment & Services
- Capitalization: $21.1B (TTM average)
Labcorp Holdings Inc. follows the US Stock Market performance with the rate: 58.7%.
Estimated limits based on current volatility of 2.0%: low 258.25$, high 268.57$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-11-26, amount 0.72$ (Y1.06%)
- Total employees count: 70000 (+4.5%) as of 2024
- US accounted for 83.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, Labor/talent shortage/retention, Liquidity and credit risks, Cybersecurity threats, Operational and conduct risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [202.29$, 286.65$]
- 2025-12-31 to 2026-12-31 estimated range: [198.63$, 286.13$]
Financial Metrics affecting the LH estimates:
- Negative: with PPE of 15.7 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 8.35
- Positive: -14.19 < Investing cash flow per share per price, % of -7.12
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0.34 <= 0.82
- Positive: 6.63 < Operating cash flow per share per price, % of 8.26
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 3.91
Short-term LH quotes
Relationship graph
Long-term LH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $11,863.90MM | $12,161.60MM | $13,008.90MM |
| Operating Expenses | $10,427.40MM | $11,436.00MM | $11,922.20MM |
| Operating Income | $1,436.50MM | $725.60MM | $1,086.70MM |
| Non-Operating Income | $-199.10MM | $-156.70MM | $-127.20MM |
| Interest Expense | $179.80MM | $199.60MM | $208.30MM |
| Income(Loss) | $1,237.40MM | $568.90MM | $959.50MM |
| Taxes | $233.90MM | $188.50MM | $212.40MM |
| Other Income(Loss) | $277.10MM | $38.80MM | $0.00MM |
| Profit(Loss)* | $1,279.10MM | $418.00MM | $746.00MM |
| Stockholders Equity | $10,096.60MM | $7,875.00MM | $8,052.20MM |
| Inventory | $470.60MM | $474.60MM | $493.20MM |
| Assets | $20,155.10MM | $16,725.10MM | $18,379.00MM |
| Operating Cash Flow | $1,955.90MM | $1,327.70MM | $1,585.80MM |
| Capital expenditure | $481.90MM | $453.60MM | $489.90MM |
| Investing Cash Flow | $-1,652.20MM | $-1,171.50MM | $-1,366.80MM |
| Financing Cash Flow | $-1,322.20MM | $-59.30MM | $779.90MM |
| Earnings Per Share** | $14.04 | $4.80 | $8.89 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.